Cytosorbents Corp (NASDAQ: CTSO) is 55.71% higher on its value in year-to-date trading and has touched a low of $0.71 and a high of $1.61 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CTSO stock was last observed hovering at around $1.0 in the last trading session, with the day’s gains setting it 0.09%.
Currently trading at $1.09, the stock is -5.18% and 7.65% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.2 million and changing 9.00% at the moment leaves the stock 5.20% off its SMA200. CTSO registered 19.78% gain for a year compared to 6-month gain of 21.11%. The firm has a 50-day simple moving average (SMA 50) of $1.01256 and a 200-day simple moving average (SMA200) of $1.036175.
The stock witnessed a 9.00% loss in the last 1 month and extending the period to 3 months gives it a 9.00%, and is -7.63% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.29% over the week and 9.75% over the month.
Cytosorbents Corp (CTSO) has around 149 employees, a market worth around $68.24M and $34.54M in sales. Profit margin for the company is -45.86%. Distance from 52-week low is 53.50% and -32.30% from its 52-week high. The company has generated returns on investments over the last 12 months (-38.59%).
with sales reaching $9.79M over the same period.The EPS is expected to grow by 42.83% this year, but quarterly earnings will post 4.97% year-over-year. Quarterly sales are estimated to shrink -1.10% in year-over-year returns.
59.0 institutions hold shares in Cytosorbents Corp (CTSO), with institutional investors hold 32.78% of the company’s shares. The shares outstanding are 62.53M, and float is at 51.94M with Short Float at 2.76%. Institutions hold 27.77% of the Float.
The top institutional shareholder in the company is AVENIR CORP with over 2.97 million shares valued at $2.09 million. The investor’s holdings represent 5.4695 of the CTSO Shares outstanding. As of 2024-06-30, the second largest holder is SKYLANDS CAPITAL, LLC with 2.84 million shares valued at $2.0 million to account for 5.2311 of the shares outstanding. The other top investors are GRANAHAN INVESTMENT MANAGEMENT, LLC which holds 2.66 million shares representing 4.9052 and valued at over $1.87 million, while VANGUARD GROUP INC holds 3.5899 of the shares totaling 1.95 million with a market value of $1.37 million.
Cytosorbents Corp (CTSO) Insider Activity
The most recent transaction is an insider purchase by MARIANI PETER J, the company’s Chief Financial Officer. SEC filings show that MARIANI PETER J bought 20,000 shares of the company’s common stock on Dec 13 ’24 at a price of $0.96 per share for a total of $19294.0. Following the purchase, the insider now owns 0.4 million shares.
Cytosorbents Corp disclosed in a document filed with the SEC on Dec 12 ’24 that MARIANI PETER J (Chief Financial Officer) bought a total of 20,000 shares of the company’s common stock. The trade occurred on Dec 12 ’24 and was made at $0.89 per share for $17872.0. Following the transaction, the insider now directly holds 0.38 million shares of the CTSO stock.
Still, SEC filings show that on Dec 11 ’24, MARIANI PETER J (Chief Financial Officer) acquired 11,363 shares at an average price of $0.89 for $10103.0. The insider now directly holds 361,363 shares of Cytosorbents Corp (CTSO).
